Results 121 to 130 of about 15,126 (225)

Psilocybin and hallucinogenic mushrooms

CNS Spectrums
AbstractPsilocybin therapy has recently emerged as a promising new treatment for depression and other mental health disorders. This chapter summarizes the most recent data on its safety and efficacy. The delivery of psilocybin therapy and its subjective effects are also presented.
Mathieu Fradet, Carlton M. Kelly, Anna J. Donnelly, Trisha Suppes   +3 more
openaire   +2 more sources

Psilocybin Response 806189750

, 2021
Psilocybin public submission for proposed amendments to the Poison Standards, November 2020 ACMS/ACCS meeting.
openaire   +1 more source

Psychedelic therapy from an existential psychological viewpoint : a theoretical analysis [PDF]

, 2016
Clinical research into the therapeutic applications of classical psychedelics has slowly but steadily resumed over the last couple of decades. Continuing the research that went dormant in the late 1960‟s, modern trials are looking into the use of high ...
Berg, Stian Hyman
core  

Return of psychedelic medicine [PDF]

, 2012
Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Humanities, Graduate Program in Science Writing, 2012.Cataloged from PDF version of thesis.Includes bibliographical references (p.
Maurer, Lauren N. (Lauren Nichole)
core  

Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials

Frontiers in Psychiatry
IntroductionPsilocybin is a classic psychedelics, which has been shown to have antidepressant effects by many studies in recent years. In this study, we aim to evaluate the efficacy, acceptability and tolerability of psilocybin in the treatment of ...
Shuping Fang, Xin Yang, Wei Zhang, Wei Zhang, Wei Zhang   +4 more
doaj   +1 more source

Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials

PCN Reports
The individual efficacy and safety of intravenous racemic (IV) ketamine, psilocybin, and theta burst stimulation (TBS) for major depressive disorder have been demonstrated through meta‐analyses of randomized controlled trials (RCTs), but the comparative ...
Itsuki Terao, Wakako Kodama
doaj   +1 more source

Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses". [PDF]

Transl Psychiatry
Kristensen J.
europepmc   +1 more source

Psilocybine [PDF]

, 2020
openaire   +1 more source

Psilocybin and Bipolar Depression: Promise and Prudence. [PDF]

CNS Drugs
Marques MG, Patarroyo-Rodriguez L, Singh B.   +2 more
europepmc   +1 more source

The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis. [PDF]

BMC Psychol
Moshfeghinia R, Mostafavi S, Jazi K, Ghasemi AR, Khosravaninezhad Y, Narayanan S, Ahmadi J, Pasalar M.   +7 more
europepmc   +1 more source